Novo Holdings — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Biomason uses biotechnology to grow biocement, producing concrete and tile products by using bacteria to bind natural materials as an alternative to Portland cement, aimed at concrete producers and the construction industry.
BiotechClimate TechConstruction TechNew MaterialsResearch Triangle Park, US
Ginger K. Dosier(Executive Officer, Director)Michael F. Noel(Director)John M. Dosier(Executive Officer)
Board seatAnders Bendsen Spohr· per SEC Form D
Co-investorsCarbonCelesta CapitalCelesta Capital
MycoWorks produces Reishi, a premium biomaterial made from Fine Mycelium, used as a sustainable leather alternative in furniture, design, and automotive products.
BiotechCircular EconomyNew MaterialsEmeryville, US
Philip Ross(Director)Michael Lindheim(Executive Officer)Matthew Scullin(Executive Officer, Director)
BoardKiersten Stead(Director)inThomas Grotkjaer(Director)
Board seatAnders Bendsen Spohr· per SEC Form D
Co-investorsDCVC (Data Collective)Hemisphere Ventures LLCWireframe Ventures8VCAgFunderDCVC Bio+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.